Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, ChemoMetec AS's Enterprise Value is kr8,505.2 Mil.
ChemoMetec AS's EBIT for the trailing twelve months (TTM) ended in Dec. 2024 was kr219.1 Mil. Therefore, ChemoMetec AS's EV-to-EBIT ratio for today is 38.81.
EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, ChemoMetec AS's Enterprise Value is kr8,505.2 Mil.
ChemoMetec AS's EBITDA for the trailing twelve months (TTM) ended in Dec. 2024 was kr237.1 Mil. Therefore, ChemoMetec AS's EV-to-EBITDA ratio for today is 35.87.
EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, ChemoMetec AS's Enterprise Value is kr8,505.2 Mil.
ChemoMetec AS's Revenue for the trailing twelve months (TTM) ended in Dec. 2024 was kr459.5 Mil. Therefore, ChemoMetec AS's EV-to-Revenue ratio for today is 18.51.
EV-to-FCF is calculated as Enterprise Value divided by its Free Cash Flow. As of today, ChemoMetec AS's Enterprise Value is kr8,505.2 Mil.
ChemoMetec AS's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2024 was kr128.2 Mil. Therefore, ChemoMetec AS's EV-to-FCF ratio for today is 66.35.
ChemoMetec AS Enterprise Value Historical Data
The historical data trend for ChemoMetec AS's Enterprise Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of ChemoMetec AS's Enterprise Value
For the Medical Devices subindustry, ChemoMetec AS's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
ChemoMetec AS's Enterprise Value Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, ChemoMetec AS's Enterprise Value distribution charts can be found below:
* The bar in red indicates where ChemoMetec AS's Enterprise Value falls into.
Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
ChemoMetec AS's Enterprise Value for the fiscal year that ended in Jun. 2024 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ChemoMetec AS (CHIX:CHEMMc) Enterprise Value Explanation
When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.
If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.
The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.
For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.
Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.
1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.
ChemoMetec AS's current Enterprise Value is kr8,505.2 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. ChemoMetec AS's EBIT for the trailing twelve months (TTM) ended in Dec. 2024 was kr219.1 Mil.
2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.
ChemoMetec AS's current Enterprise Value is kr8,505.2 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. ChemoMetec AS's EBITDA for the trailing twelve months (TTM) ended in Dec. 2024 was kr237.1 Mil.
ChemoMetec AS's current Enterprise Value is kr8,505.2 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. ChemoMetec AS's Revenue for the trailing twelve months (TTM) ended in Dec. 2024 was kr459.5 Mil.
ChemoMetec AS's current Enterprise Value is kr8,505.2 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. ChemoMetec AS's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2024 was kr128.2 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ChemoMetec AS Enterprise Value Related Terms
Thank you for viewing the detailed overview of ChemoMetec AS's Enterprise Value provided by GuruFocus.com. Please click on the following links to see related term pages.
ChemoMetec AS specializes in designing, developing, and producing instruments using patented technology in cell counting and evaluation. It is engaged in the manufacturing and marketing of analytical instruments used for quantitative analysis of cells in liquids. Its applications include Cell Analysis and counting of Mammalian Cells, Yeast Cells, and Sperm Cells. It provides platforms for the determination of viability and cell count of yeast, veterinary semen, mammalian cells, and somatic cells as well as image analysis. It has four segments instruments; consumables; services and others, and the majority of its revenue is generated from the Consumable segment.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
CHIX:CHEMMC has been successfully added to your 